| HOME >> BIOLOGY >> TECHNOLOGY |
step-up in basis - - (170) -
Amortization of purchased
intangible assets (199) - (694) -
Non-GAAP measure of cost of goods
sold $20,989 $12,390 $67,516 $48,216
Gross Margin on Product Sales per
GAAP 42% 42% 41% 41%
Gross Margin on Product Sales per
Non-GAAP 43% 43% 42% 41%
Gross Margin on Total Revenues per
GAAP 47% 47% 47% 44%
Gross Margin on Total Revenues per
Non-GAAP 48% 47% 48% 45%
Research and development $8,717 $6,682 $31,449 $23,886
Amortization of purchased
intangible assets $(23) $(32) $(95) $(40)
Stock compensation expense (1,184) (924) (4,294) (2,839)
Non-GAAP measure of cost of research
and development $7,510 $5,726 $27,060 $21,007
Non-GAAP R&D measure as percent of
Total Revenues 19% 24% 21% 24%
Selling, general and administrative $12,692 $7,257 $41,081 $26,470
Amortization of purchased
intangible assets $(14) $- $(51) $-
Stock compensation expense (2,373) (1,160) (6,032) (3,907)
Non-GAAP measure of cost of selling,
general and administrative $10,305 $6,097 $34,998 $22,563
Non-GAAP SG&A measure as percent of
Total Revenues 25% 26% 27% 26%
Net Loss $(5,288) $(8,301) $(21,423) $(25,985)
Stock compensation expense 3,821 2
'/>"/>
| SOURCE Cepheid Copyright©2008 PR Newswire. All rights reserved |